Strategy For Host Cell Protein Control
Source: Cytiva

Advances in the life sciences industry have led to the creation of life-changing therapeutics that transform human health. A critical aspect of therapeutic development and manufacture is host cell protein (HCP) detection, quantitation, and removal from drug substances, to ensure efficacy and prevent immunogenicity. These processes require robust technologies that deliver integrated performance, backed by trusted expertise.
This article reviews a range of solutions to support scientists and developers in creating an effective strategy for HCP control.
access the Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.
Subscribe to Bioprocess Online
X
Subscribe to Bioprocess Online
Cytiva
This website uses cookies to ensure you get the best experience on our website. Learn more